Christopher Y Thomas

Publication Activity (10 Years)

Years Active: 2024-2024
Publications (10 Years): 3

Top Topics

Chemotherapy Induced

Epidermal Growth Factor Receptor

Top Venues

Cancer research communications

This page only lists publications with an associated author ORCID identifier.

Publications

Rhonda L Bitting, Janet A Tooze, Michael Goodman, Donald C Vile, Jessica M Brown, Christopher Y Thomas, Morgan Neve, Mitra Kooshki, Safoa Addo, Pierre L Triozzi, Purnima Dubey
Low-dose Paclitaxel with Pembrolizumab Enhances Clinical and Immunologic Responses in Platinum-refractory Urothelial Carcinoma. Cancer research communications 4 (2) (2024)
Rhonda L Bitting, Janet A Tooze, Michael Goodman, Donald C Vile, Jessica M Brown, Christopher Y Thomas, Morgan Neve, Mitra Kooshki, Safoa Addo, Pierre L Triozzi, Purnima Dubey
Low Dose Paclitaxel with Pembrolizumab Enhances Clinical and Immunologic Responses in Platinum Refractory Urothelial Carcinoma. Cancer research communications (2024)
Rhonda L Bitting, Janet A Tooze, Michael Goodman, Donald C Vile, Jessica M Brown, Christopher Y Thomas, Morgan Neve, Mitra Kooshki, Safoa Addo, Pierre L Triozzi, Purnima Dubey
Low-dose Paclitaxel with Pembrolizumab Enhances Clinical and Immunologic Responses in Platinum-refractory Urothelial Carcinoma. Cancer research communications 4 (2) (2024)